KINASE INHIBITOR
The invention is directed to a compound of formula (I) and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
13.03.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention is directed to a compound of formula (I) and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases. |
---|---|
AbstractList | The invention is directed to a compound of formula (I) and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases. |
Author | ALLEN, ELIZABETH M ZILBERSTEIN, ASHER YU, KIN T GILLESPY, TIMOTHY A EYNOTT, PAUL |
Author_xml | – fullname: EYNOTT, PAUL – fullname: ALLEN, ELIZABETH M – fullname: GILLESPY, TIMOTHY A – fullname: ZILBERSTEIN, ASHER – fullname: YU, KIN T |
BookMark | eNrjYmDJy89L5WQQ8Pb0cwx2VfD08_B08gzxD-JhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjkZmZsaG5qbOxoRVAABIKR5a |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | INHIBITEUR DE KINASES |
ExternalDocumentID | CA2663175C |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2663175C3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:53:12 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2663175C3 |
Notes | Application Number: CA20072663175 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120313&DB=EPODOC&CC=CA&NR=2663175C |
ParticipantIDs | epo_espacenet_CA2663175C |
PublicationCentury | 2000 |
PublicationDate | 20120313 |
PublicationDateYYYYMMDD | 2012-03-13 |
PublicationDate_xml | – month: 03 year: 2012 text: 20120313 day: 13 |
PublicationDecade | 2010 |
PublicationYear | 2012 |
RelatedCompanies | SANOFI-AVENTIS |
RelatedCompanies_xml | – name: SANOFI-AVENTIS |
Score | 2.8401554 |
Snippet | The invention is directed to a compound of formula (I) and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | KINASE INHIBITOR |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120313&DB=EPODOC&locale=&CC=CA&NR=2663175C |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUo0BjYqgDkt0SLFTNfEMBWUpYwNdVOTTdNSTEBVUDJoN7Kvn5lHqIlXhGkEE0MGbC8M-JzQcvDhiMAclQzM7yXg8roAMYjlAl5bWayflAkUyrd3C7F1UYP2jg2NQEcRqrk42boG-Lv4O6s5O9s6O6r5BdkC6yFQTenMzMAKbESbg_KCa5gTaE9KAXKF4ibIwBYANCuvRIiBKTVPmIHTGXbvmjADhy90uhvIhOa8YhEGAWA32zHYVcHTz8PTyTPEP0iUQd7NNcTZQxdodDzcF_HOjjA3GIsxsAD79qkSDAomiWkGlilpxqbGyaYmqakmScDCycw4zSzJ3NgsLck0WZJBApcpUrilpBm4QGEBWiplaCzDwFJSVJoqC6w7S5LkwN4GAKFQcEw |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQIwTMEDjuR1QbxV0STs4VKhNW7WwttMoaLeqj0RwGRMr4u_jVC1w2S1KJMux9OWzE9sBuB5nBJ0KRFp2Vxoq1biEFNFUXuiipJKCClmNHEaG_0IfF_qiA29tLUzdJ_S7bo6IiCoQ71V9Xq_-LrGcOrdyfZO_49THg5eYjtJEx9pYtiJUHNt0Z7ETM4Uxk1lKNDeRhyRTsi3YRgd7IrHgvtqyJmX1n1C8A9iZoaxldQgdvuxDj7X_rvVhN2yeu3HYIG99BPsYZlvP7iiI_MAOknh-DEPPTZivouj0dxcps1odyAl0MbbnAxjRTNzel4LopNAp5zRH1QwijHxCDJHrxSkMNkk527w0hJ6fhNN0GkRP57An7SLTpjRyAd3q84tfIo9W-VVtgh8Pp3M_ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=KINASE+INHIBITOR&rft.inventor=EYNOTT%2C+PAUL&rft.inventor=ALLEN%2C+ELIZABETH+M&rft.inventor=GILLESPY%2C+TIMOTHY+A&rft.inventor=ZILBERSTEIN%2C+ASHER&rft.inventor=YU%2C+KIN+T&rft.date=2012-03-13&rft.externalDBID=C&rft.externalDocID=CA2663175C |